Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Stryker by Year
Stryker — FDA MAUDE Adverse Event Reports Total (reports)
Stryker Stryker: 10,367 in FY2025, down 0.8% from a year earlier.
Latest, FY2025
10,367
Period ended Dec 31, 2025
Change on a year earlier
-0.8%
10,455 in FY2024
History
12 years
Since FY2014
Sources
1
U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker
Where the FY2025 figure comes from
Source: U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Reported in U.S. FDA openFDA Device Adverse Events API.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up stryker
Cite this data
StockData. (2026). Stryker Stryker, annual FY2014–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/ext-fda-maude
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.